New US Cardiology Guidelines for Cholesterol and Heart Disease Prevention

The American College of Cardiology (ACC), the American Heart Association (AHA), and nine other leading medical associations released an updated guideline for the management of dyslipidemia on March 13, 2026. Dyslipidemia is defined as abnormal levels of one or more types of lipoproteins or lipids in the blood, including triglycerides and cholesterol.

The updated guidance aims to provide a comprehensive framework for assessing and treating various blood lipids to lower the risk of developing atherosclerotic cardiovascular disease (ASCVD). ASCVD occurs when fatty deposits build up in the arteries and is currently the leading cause of death globally.

The document was jointly published on March 13, 2026, in Circulation, the flagship journal of the American Heart Association, and JACC, the flagship journal of the American College of Cardiology.

Focus on Early Intervention and Lifestyle

A primary focus of the new guidelines is the implementation of earlier interventions. The associations emphasize the role of healthy lifestyle changes in managing lipid levels and reducing cardiovascular risk.

Recommended lifestyle modifications include:

• Maintaining a healthy weight
• Engaging in regular physical activity
• Avoiding the use of tobacco products
• Prioritizing healthy sleep habits

In addition to lifestyle changes, the guidelines advise taking cholesterol-lowering medication when it is recommended by a health care professional.

Updated Risk Assessment and LDL-C Goals

The updated guidelines reinforce the need for lower low-density lipoprotein-cholesterol (LDL-C) goals and a specific percent reduction based on an individual’s risk. These measures are intended to reduce the risk of stroke and heart attack by limiting lifetime exposure to unhealthy lipids.

For individuals without existing cardiovascular disease, optimal LDL-C levels are considered to be below 100 mg/dL.

To assist in the primary prevention of ASCVD, the guidelines introduce a more contemporary cardiovascular disease risk calculator. This tool, known as Predicting Risk of Cardiovascular Disease EVENTs (PREVENT), is now recommended for identifying those at risk.

Public Health Context

The urgency of these guidelines is underscored by the prevalence of lipid issues in the United States. It is estimated that 1 in 4 U.S. Adults has high levels of LDL-C, which increases the likelihood of experiencing a stroke or heart attack.

By consolidating evidence-based recommendations into a single document, the ACC and AHA intend to offer a one-stop shop for medical professionals to best assess and treat blood lipids effectively.